Mebendazole (Vermox) and H2 Antagonists: Clinically Significant Interaction
Cimetidine significantly increases mebendazole serum concentrations and should be considered when enhanced mebendazole efficacy is desired, while other H2 antagonists (ranitidine, famotidine) have minimal interaction potential and can be used safely with mebendazole.
Mechanism and Clinical Evidence
The interaction between mebendazole and cimetidine is well-documented and pharmacologically significant. Cimetidine increases maximum serum concentrations of mebendazole through inhibition of hepatic cytochrome P450 enzymes 1. In a clinical study, cimetidine (400 mg three times daily for 30 days) significantly increased maximum serum mebendazole concentrations (P < 0.01) in patients receiving mebendazole 1.5 g three times daily 1. This interaction proved therapeutically beneficial, resulting in complete resolution of previously unresponsive hydatid cysts 1.
A systematic review confirmed that cimetidine increases the Cmax (maximum concentration) of mebendazole, while no major interactions were documented with other commonly used medications 2.
Differential Effects Among H2 Antagonists
The key distinction lies in the metabolic profiles of different H2 antagonists:
Cimetidine: Inhibits multiple CYP450 enzymes (CYP1A2, 2C9, 2C19, 2D6, 2E1, and 3A4) 3, 4, making it the most likely to interact with mebendazole metabolism
Ranitidine: Interacts only weakly with cytochrome P-450 3
Famotidine and nizatidine: Do not bind to the cytochrome P-450 system and therefore have low potential to interact with mebendazole 3
Clinical Recommendations
For routine helminthic infections: Use famotidine or ranitidine if H2 antagonist therapy is needed concurrently with mebendazole, as these agents pose minimal interaction risk.
For difficult-to-treat parasitic infections (e.g., hepatic hydatid cysts, tissue-invasive helminthic infections): Consider intentional co-administration of cimetidine with mebendazole to enhance mebendazole bioavailability and therapeutic efficacy 1. The typical cimetidine regimen studied was 400 mg three times daily 1.
Monitor for: Enhanced mebendazole effects (both therapeutic and potential adverse effects) when cimetidine is co-administered. The interaction is predictable and dose-dependent based on cimetidine's enzyme inhibition.
Important Caveats
- Cimetidine has additional concerns including associations with liver disease and gynecomastia 5
- The interaction is beneficial when enhanced mebendazole absorption is desired but may increase risk of adverse effects in standard dosing scenarios
- If switching between H2 antagonists during mebendazole therapy, be aware that changing from cimetidine to famotidine/ranitidine will decrease mebendazole exposure